Amgen Debuts Oncology Biosimilars Bevacizumab And Trastuzumab In US

 
• By David Wallace
  
Amgen
Amgen has launched two US biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business